Skip to content

HCA Healthcare

NYSE: HCA · USD

HCA Healthcare financials

6 charts

Revenue

USD millions

$20,230M
HCA Healthcare Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodRevenue
FY 2011 Q1Unavailable; Change unavailable vs FY 2010 Q4
FY 2011 Q2Unavailable; Change unavailable vs FY 2011 Q1
FY 2011 Q3Unavailable; Change unavailable vs FY 2011 Q2
FY 2011 Q4Unavailable; Change unavailable vs FY 2011 Q3
FY 2012 Q1Unavailable; Change unavailable vs FY 2011 Q4
FY 2012 Q2Unavailable; Change unavailable vs FY 2012 Q1
FY 2012 Q3Unavailable; Change unavailable vs FY 2012 Q2
FY 2012 Q4Unavailable; Change unavailable vs FY 2012 Q3
FY 2013 Q1Unavailable; Change unavailable vs FY 2012 Q4
FY 2013 Q2Unavailable; Change unavailable vs FY 2013 Q1
FY 2013 Q3Unavailable; Change unavailable vs FY 2013 Q2
FY 2013 Q4Unavailable; Change unavailable vs FY 2013 Q3
FY 2014 Q1Unavailable; Change unavailable vs FY 2013 Q4
FY 2014 Q2Unavailable; Change unavailable vs FY 2014 Q1
FY 2014 Q3Unavailable; Change unavailable vs FY 2014 Q2
FY 2014 Q4Unavailable; Change unavailable vs FY 2014 Q3
FY 2015 Q1Unavailable; Change unavailable vs FY 2014 Q4
FY 2015 Q2Unavailable; Change unavailable vs FY 2015 Q1
FY 2015 Q3Unavailable; Change unavailable vs FY 2015 Q2
FY 2015 Q4Unavailable; Change unavailable vs FY 2015 Q3
FY 2016 Q1Unavailable; Change unavailable vs FY 2015 Q4
FY 2016 Q2Unavailable; Change unavailable vs FY 2016 Q1
FY 2016 Q3Unavailable; Change unavailable vs FY 2016 Q2
FY 2016 Q4Unavailable; Change unavailable vs FY 2016 Q3
FY 2017 Q1$10,623M; Change unavailable vs FY 2016 Q4
FY 2017 Q2$10,733M; +1.0% vs FY 2017 Q1
FY 2017 Q3$10,696M; −0.3% vs FY 2017 Q2
FY 2017 Q4$11,562M; +8.1% vs FY 2017 Q3
FY 2018 Q1$11,423M; −1.2% vs FY 2017 Q4
FY 2018 Q2$11,529M; +0.9% vs FY 2018 Q1
FY 2018 Q3$11,451M; −0.7% vs FY 2018 Q2
FY 2018 Q4$12,274M; +7.2% vs FY 2018 Q3
FY 2019 Q1$12,517M; +2.0% vs FY 2018 Q4
FY 2019 Q2$12,602M; +0.7% vs FY 2019 Q1
FY 2019 Q3$12,694M; +0.7% vs FY 2019 Q2
FY 2019 Q4$13,523M; +6.5% vs FY 2019 Q3
FY 2020 Q1$12,861M; −4.9% vs FY 2019 Q4
FY 2020 Q2$11,068M; −13.9% vs FY 2020 Q1
FY 2020 Q3$13,311M; +20.3% vs FY 2020 Q2
FY 2020 Q4$14,293M; +7.4% vs FY 2020 Q3
FY 2021 Q1$13,977M; −2.2% vs FY 2020 Q4
FY 2021 Q2$14,435M; +3.3% vs FY 2021 Q1
FY 2021 Q3$15,276M; +5.8% vs FY 2021 Q2
FY 2021 Q4Unavailable; Change unavailable vs FY 2021 Q3
FY 2022 Q1$14,945M; Change unavailable vs FY 2021 Q4
FY 2022 Q2$14,820M; −0.8% vs FY 2022 Q1
FY 2022 Q3$14,971M; +1.0% vs FY 2022 Q2
FY 2022 Q4$15,497M; +3.5% vs FY 2022 Q3
FY 2023 Q1$15,591M; +0.6% vs FY 2022 Q4
FY 2023 Q2$15,861M; +1.7% vs FY 2023 Q1
FY 2023 Q3$16,213M; +2.2% vs FY 2023 Q2
FY 2023 Q4$17,303M; +6.7% vs FY 2023 Q3
FY 2024 Q1$17,339M; +0.2% vs FY 2023 Q4
FY 2024 Q2$17,492M; +0.9% vs FY 2024 Q1
FY 2024 Q3$17,487M; 0.0% vs FY 2024 Q2
FY 2024 Q4$18,285M; +4.6% vs FY 2024 Q3
FY 2025 Q1$18,321M; +0.2% vs FY 2024 Q4
FY 2025 Q2$18,605M; +1.6% vs FY 2025 Q1
FY 2025 Q3$19,161M; +3.0% vs FY 2025 Q2
FY 2025 Q4$19,513M; +1.8% vs FY 2025 Q3
FY 2026 Q1$19,109M; −2.1% vs FY 2025 Q4
FY 2026 Q2$20,230M; +5.9% vs FY 2026 Q1
Mar 31, 2011 through Oct 22, 2026

Free cash flow

USD millions

$1,104M
HCA Healthcare Free cash flow. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodFree cash flow
FY 2011 Q1$589M; Change unavailable vs FY 2010 Q4
FY 2011 Q2$301M; −48.9% vs FY 2011 Q1
FY 2011 Q3$486M; +61.5% vs FY 2011 Q2
FY 2011 Q4$878M; +80.7% vs FY 2011 Q3
FY 2012 Q1$462M; −47.4% vs FY 2011 Q4
FY 2012 Q2$1,011M; +118.8% vs FY 2012 Q1
FY 2012 Q3$171M; −83.1% vs FY 2012 Q2
FY 2012 Q4$669M; +291.2% vs FY 2012 Q3
FY 2013 Q1$336M; −49.8% vs FY 2012 Q4
FY 2013 Q2$322M; −4.2% vs FY 2013 Q1
FY 2013 Q3$449M; +39.4% vs FY 2013 Q2
FY 2013 Q4$630M; +40.3% vs FY 2013 Q3
FY 2014 Q1$43M; −93.2% vs FY 2013 Q4
FY 2014 Q2$737M; +1614.0% vs FY 2014 Q1
FY 2014 Q3Unavailable; Change unavailable vs FY 2014 Q2
FY 2014 Q4$933M; Change unavailable vs FY 2014 Q3
FY 2015 Q1$572M; −38.7% vs FY 2014 Q4
FY 2015 Q2$499M; −12.8% vs FY 2015 Q1
FY 2015 Q3$534M; +7.0% vs FY 2015 Q2
FY 2015 Q4$754M; +41.2% vs FY 2015 Q3
FY 2016 Q1$890M; +18.0% vs FY 2015 Q4
FY 2016 Q2$686M; −22.9% vs FY 2016 Q1
FY 2016 Q3$494M; −28.0% vs FY 2016 Q2
FY 2016 Q4$823M; +66.6% vs FY 2016 Q3
FY 2017 Q1$709M; −13.9% vs FY 2016 Q4
FY 2017 Q2$671M; −5.4% vs FY 2017 Q1
FY 2017 Q3$279M; −58.4% vs FY 2017 Q2
FY 2017 Q4$752M; +169.5% vs FY 2017 Q3
FY 2018 Q1$606M; −19.4% vs FY 2017 Q4
FY 2018 Q2$702M; +15.8% vs FY 2018 Q1
FY 2018 Q3$875M; +24.6% vs FY 2018 Q2
FY 2018 Q4$1,022M; +16.8% vs FY 2018 Q3
FY 2019 Q1$193M; −81.1% vs FY 2018 Q4
FY 2019 Q2$1,033M; +435.2% vs FY 2019 Q1
FY 2019 Q3$987M; −4.5% vs FY 2019 Q2
FY 2019 Q4$1,231M; +24.7% vs FY 2019 Q3
FY 2020 Q1$522M; −57.6% vs FY 2019 Q4
FY 2020 Q2$7,978M; +1428.4% vs FY 2020 Q1
FY 2020 Q3$2,228M; −72.1% vs FY 2020 Q2
FY 2020 Q4$-4,331M; −294.4% vs FY 2020 Q3
FY 2021 Q1$1,334M; +130.8% vs FY 2020 Q4
FY 2021 Q2$1,409M; +5.6% vs FY 2021 Q1
FY 2021 Q3$1,388M; −1.5% vs FY 2021 Q2
FY 2021 Q4$1,251M; −9.9% vs FY 2021 Q3
FY 2022 Q1$484M; −61.3% vs FY 2021 Q4
FY 2022 Q2$550M; +13.6% vs FY 2022 Q1
FY 2022 Q3$1,889M; +243.5% vs FY 2022 Q2
FY 2022 Q4$1,204M; −36.3% vs FY 2022 Q3
FY 2023 Q1$606M; −49.7% vs FY 2022 Q4
FY 2023 Q2$1,234M; +103.6% vs FY 2023 Q1
FY 2023 Q3$1,332M; +7.9% vs FY 2023 Q2
FY 2023 Q4$1,515M; +13.7% vs FY 2023 Q3
FY 2024 Q1$1,351M; −10.8% vs FY 2023 Q4
FY 2024 Q2$690M; −48.9% vs FY 2024 Q1
FY 2024 Q3$2,324M; +236.8% vs FY 2024 Q2
FY 2024 Q4$1,274M; −45.2% vs FY 2024 Q3
FY 2025 Q1$660M; −48.2% vs FY 2024 Q4
FY 2025 Q2$3,034M; +359.7% vs FY 2025 Q1
FY 2025 Q3$3,128M; +3.1% vs FY 2025 Q2
FY 2025 Q4$870M; −72.2% vs FY 2025 Q3
FY 2026 Q1$895M; +2.9% vs FY 2025 Q4
FY 2026 Q2$1,104M; +23.4% vs FY 2026 Q1

Net margin

%

8.4%
HCA Healthcare Net margin. Reported fiscal history.
Fiscal period%
FY 2011 Q1—
FY 2011 Q2—
FY 2011 Q3—
FY 2011 Q4—
FY 2012 Q1—
FY 2012 Q2—
FY 2012 Q3—
FY 2012 Q4—
FY 2013 Q1—
FY 2013 Q2—
FY 2013 Q3—
FY 2013 Q4—
FY 2014 Q1—
FY 2014 Q2—
FY 2014 Q3—
FY 2014 Q4—
FY 2015 Q1—
FY 2015 Q2—
FY 2015 Q3—
FY 2015 Q4—
FY 2016 Q1—
FY 2016 Q2—
FY 2016 Q3—
FY 2016 Q4—
FY 2017 Q16.2%
FY 2017 Q26.12%
FY 2017 Q33.98%
FY 2017 Q44.1%
FY 2018 Q110.01%
FY 2018 Q27.11%
FY 2018 Q36.63%
FY 2018 Q48.67%
FY 2019 Q18.3%
FY 2019 Q26.21%
FY 2019 Q34.82%
FY 2019 Q47.92%
FY 2020 Q14.52%
FY 2020 Q29.75%
FY 2020 Q35.02%
FY 2020 Q49.98%
FY 2021 Q110.18%
FY 2021 Q210.05%
FY 2021 Q314.85%
FY 2021 Q4—
FY 2022 Q18.52%
FY 2022 Q27.79%
FY 2022 Q37.57%
FY 2022 Q413.43%
FY 2023 Q18.74%
FY 2023 Q27.52%
FY 2023 Q36.66%
FY 2023 Q49.29%
FY 2024 Q19.18%
FY 2024 Q28.35%
FY 2024 Q37.26%
FY 2024 Q47.86%
FY 2025 Q18.79%
FY 2025 Q28.88%
FY 2025 Q38.57%
FY 2025 Q49.62%
FY 2026 Q18.48%
FY 2026 Q28.4%

P/E

× · TTM · Daily

15.22×
HCA Healthcare P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date× · TTM · DailyFinancials through
2014-02-287.29×2012-09-30
2014-03-317.48×2012-09-30
2014-04-307.41×2012-09-30
2014-05-307.55×2012-09-30
2014-06-308.03×2012-09-30
2014-07-319.3×2012-09-30
2014-08-299.95×2012-09-30
2014-09-3010.04×2012-09-30
2014-10-319.98×2012-09-30
2014-11-289.93×2012-09-30
2014-12-3110.45×2012-09-30
2015-01-3010.08×2012-09-30
2015-02-2722.93×2013-09-30
2015-03-3124.12×2013-09-30
2015-04-3023.73×2013-09-30
2015-05-2926.23×2013-09-30
2015-06-3029.08×2013-09-30
2015-07-3129.82×2013-09-30
2015-08-3127.77×2013-09-30
2015-09-3024.8×2013-09-30
2015-10-3022.05×2013-09-30
2015-11-3021.82×2013-09-30
2015-12-3121.68×2013-09-30
2016-01-2922.31×2013-09-30
2016-02-2913.52×2015-12-31
2016-03-3115.25×2015-12-31
2016-04-2915.75×2015-12-31
2016-05-3115.24×2015-12-31
2016-06-3015.05×2015-12-31
2016-07-2915.07×2015-12-31
2016-08-3112.64×2016-06-30
2016-09-3012.65×2016-06-30
2016-10-3112.8×2016-06-30
2016-11-3010.82×2016-09-30
2016-12-3011.3×2016-09-30
2017-01-3112.26×2016-09-30
2017-02-2813.32×2016-09-30
2017-03-3113.59×2016-09-30
2017-04-2812.86×2016-09-30
2017-05-3112.5×2016-09-30
2017-06-3013.31×2016-09-30
2017-07-3112.26×2016-09-30
2017-08-3112.01×2016-09-30
2017-09-2912.15×2016-09-30
2017-10-3111.55×2016-09-30
2017-11-3012.98×2016-09-30
2017-12-2913.41×2016-09-30
2018-01-3115.44×2016-09-30
2018-02-2815.15×2016-09-30
2018-03-2914.81×2016-09-30
2018-04-3014.62×2016-09-30
2018-05-3115.75×2016-09-30
2018-06-2915.66×2016-09-30
2018-07-3118.97×2016-09-30
2018-08-3120.47×2016-09-30
2018-09-2821.24×2016-09-30
2018-10-3120.38×2016-09-30
2018-11-3021.98×2016-09-30
2018-12-3119×2016-09-30
2019-01-3121.29×2016-09-30
2019-02-2812.96×2018-12-31
2019-03-2912.15×2018-12-31
2019-04-3011.86×2018-12-31
2019-05-3111.27×2018-12-31
2019-06-2812.59×2018-12-31
2019-07-3112.44×2018-12-31
2019-08-3011.49×2019-06-30
2019-09-3011.51×2019-06-30
2019-10-3112.76×2019-06-30
2019-11-2913.77×2019-09-30
2019-12-3114.68×2019-09-30
2020-01-3113.79×2019-09-30
2020-02-2812.57×2019-12-31
2020-03-318.89×2019-12-31
2020-04-3010.87×2019-12-31
2020-05-2912.07×2020-03-31
2020-06-3010.96×2020-03-31
2020-07-3112.94×2020-06-30
2020-08-3113.87×2020-06-30
2020-09-3012.74×2020-06-30
2020-10-3012.52×2020-09-30
2020-11-3015.16×2020-09-30
2020-12-3116.61×2020-09-30
2021-01-2916.41×2020-09-30
2021-02-2617.38×2020-09-30
2021-03-3119.02×2020-09-30
2021-04-3020.31×2020-09-30
2021-05-2821.7×2020-09-30
2021-06-3020.88×2020-09-30
2021-07-3025.07×2020-09-30
2021-08-3125.55×2020-09-30
2021-09-3024.52×2020-09-30
2021-10-2925.3×2020-09-30
2021-11-3022.79×2020-09-30
2021-12-3125.95×2020-09-30
2022-01-3124.25×2020-09-30
2022-02-2811.35×2021-12-31
2022-03-3111.36×2021-12-31
2022-04-299.73×2021-12-31
2022-05-319.5×2022-03-31
2022-06-307.59×2022-03-31
2022-07-299.59×2022-03-31
2022-08-319×2022-06-30
2022-09-308.36×2022-06-30
2022-10-319.89×2022-06-30
2022-11-3012.95×2022-09-30
2022-12-3012.94×2022-09-30
2023-01-3113.75×2022-09-30
2023-02-2812.32×2022-12-31
2023-03-3113.35×2022-12-31
2023-04-2814.08×2023-03-31
2023-05-3112.95×2023-03-31
2023-06-3014.87×2023-03-31
2023-07-3113.37×2023-03-31
2023-08-3113.37×2023-06-30
2023-09-2911.86×2023-06-30
2023-10-3110.9×2023-09-30
2023-11-3012.07×2023-09-30
2023-12-2913.04×2023-09-30
2024-01-3114.69×2023-09-30
2024-02-2916.13×2023-12-31
2024-03-2817.25×2023-12-31
2024-04-3016.03×2023-12-31
2024-05-3116.65×2024-03-31
2024-06-2815.74×2024-03-31
2024-07-3116.71×2024-06-30
2024-08-3018.21×2024-06-30
2024-09-3018.7×2024-06-30
2024-10-3116.51×2024-06-30
2024-11-2914.34×2024-09-30
2024-12-3113.16×2024-09-30
2025-01-3114.46×2024-09-30
2025-02-2813.58×2024-12-31
2025-03-3115.32×2024-12-31
2025-04-3015.3×2024-12-31
2025-05-3016.46×2025-03-31
2025-06-3016.54×2025-03-31
2025-07-3115.28×2025-03-31
2025-08-2916.37×2025-06-30
2025-09-3017.27×2025-06-30
2025-10-3117.11×2025-09-30
2025-11-2818.92×2025-09-30
2025-12-3117.38×2025-09-30
2026-01-3018.18×2025-09-30
2026-02-2718.01×2025-12-31
2026-03-3116.09×2025-12-31
2026-04-3014.49×2026-03-31
2026-05-2912.63×2026-03-31
2026-06-3013.01×2026-03-31
2026-07-3113.12×2026-06-30
2026-08-3113.5×2026-06-30
2026-09-3013.9×2026-06-30
2026-10-2215.22×2026-06-30
Mean 15.28×Median 14.08×8% above median

ROIC

% · Annual / TTM

—
Operating income is unavailable in the extracted statements for this period.
HCA Healthcare ROIC. Reported fiscal history.
Fiscal period% · Annual / TTM
FY 2011 Q1—
FY 2011 Q2—
FY 2011 Q3—
FY 2011 Q4—
FY 2012 Q1—
FY 2012 Q2—
FY 2012 Q3—
FY 2012 Q4—
FY 2013 Q1—
FY 2013 Q2—
FY 2013 Q3—
FY 2013 Q4—
FY 2014 Q1—
FY 2014 Q2—
FY 2014 Q3—
FY 2014 Q4—
FY 2015 Q1—
FY 2015 Q2—
FY 2015 Q3—
FY 2015 Q4—
FY 2016 Q1—
FY 2016 Q2—
FY 2016 Q3—
FY 2016 Q4—
FY 2017 Q1—
FY 2017 Q2—
FY 2017 Q3—
FY 2017 Q4—
FY 2018 Q1—
FY 2018 Q2—
FY 2018 Q3—
FY 2018 Q4—
FY 2019 Q1—
FY 2019 Q2—
FY 2019 Q3—
FY 2019 Q4—
FY 2020 Q1—
FY 2020 Q2—
FY 2020 Q3—
FY 2020 Q4—
FY 2021 Q1—
FY 2021 Q2—
FY 2021 Q3—
FY 2021 Q4—
FY 2022 Q1—
FY 2022 Q2—
FY 2022 Q3—
FY 2022 Q4—
FY 2023 Q1—
FY 2023 Q2—
FY 2023 Q3—
FY 2023 Q4—
FY 2024 Q1—
FY 2024 Q2—
FY 2024 Q3—
FY 2024 Q4—
FY 2025 Q1—
FY 2025 Q2—
FY 2025 Q3—
FY 2025 Q4—
FY 2026 Q1—
FY 2026 Q2—

Capital allocation

% of tracked cash uses

$6,016M
HCA Healthcare capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2011 Q150.23% · $329MUnavailableUnavailable4.58% · $30M45.19% · $296M100% · $655M
FY 2011 Q226.94% · $447MUnavailableUnavailable0% · $0M73.06% · $1,212M100% · $1,659M
FY 2011 Q37.2% · $394MUnavailableUnavailable0.02% · $1M92.78% · $5,075M100% · $5,470M
FY 2011 Q489.93% · $509MUnavailable0% · $0M0% · $0M10.07% · $57M100% · $566M
FY 2012 Q123.76% · $335MUnavailableUnavailable69.65% · $982M6.6% · $93M100% · $1,410M
FY 2012 Q246.58% · $449MUnavailableUnavailable0% · $0M53.42% · $515M100% · $964M
FY 2012 Q385.51% · $484MUnavailableUnavailable0.18% · $1M14.31% · $81M100% · $566M
FY 2012 Q413.17% · $594MUnavailableUnavailable47.99% · $2,165M38.84% · $1,752M100% · $4,511M
FY 2013 Q134.98% · $404MUnavailableUnavailable0.87% · $10M64.16% · $741M100% · $1,155M
FY 2013 Q294.8% · $492MUnavailableUnavailable0% · $0M5.2% · $27M100% · $519M
FY 2013 Q345.74% · $451MUnavailableUnavailable0.3% · $3M53.96% · $532M100% · $986M
FY 2013 Q462.02% · $596MUnavailableUnavailable0.31% · $3M37.67% · $362M100% · $961M
FY 2014 Q142.15% · $400MUnavailableUnavailable0.74% · $7M57.11% · $542M100% · $949M
FY 2014 Q214.86% · $513MUnavailableUnavailable0% · $0M85.14% · $2,940M100% · $3,453M
FY 2014 Q392.97% · $569MUnavailable0% · $0M0% · $0M7.03% · $43M100% · $612M
FY 2014 Q420.82% · $694MUnavailable30% · $1,000M0% · $0M49.17% · $1,639M100% · $3,333M
FY 2015 Q127.72% · $446MUnavailable22.75% · $366M0.37% · $6M49.16% · $791M100% · $1,609M
FY 2015 Q214% · $558MUnavailable14.4% · $574MUnavailable71.59% · $2,853M100% · $3,985M
FY 2015 Q352.94% · $567MUnavailable41.64% · $446MUnavailable5.42% · $58M100% · $1,071M
FY 2015 Q426.51% · $804MUnavailable33.33% · $1,011MUnavailable40.16% · $1,218M100% · $3,033M
FY 2016 Q116.21% · $509MUnavailable19.77% · $621MUnavailable64.02% · $2,011M100% · $3,141M
FY 2016 Q233.93% · $663MUnavailable63.31% · $1,237MUnavailable2.76% · $54M100% · $1,954M
FY 2016 Q320.78% · $712MUnavailable10.36% · $355MUnavailable68.86% · $2,359M100% · $3,426M
FY 2016 Q459.8% · $876MUnavailable36.72% · $538MUnavailable3.48% · $51M100% · $1,465M
FY 2017 Q155.01% · $571MUnavailable40.85% · $424MUnavailable4.14% · $43M100% · $1,038M
FY 2017 Q255.24% · $733MUnavailable40.84% · $542MUnavailable3.92% · $52M100% · $1,327M
FY 2017 Q339.56% · $729MUnavailable27.62% · $509MUnavailable32.83% · $605M100% · $1,843M
FY 2017 Q460.96% · $982MUnavailable35.75% · $576MUnavailable3.29% · $53M100% · $1,611M
FY 2018 Q153.8% · $694MUnavailable32.79% · $423M9.53% · $123M3.88% · $50M100% · $1,290M
FY 2018 Q257.78% · $880MUnavailable30.86% · $470M8.01% · $122M3.35% · $51M100% · $1,523M
FY 2018 Q330% · $846MUnavailable10.71% · $302M4.29% · $121M55% · $1,551M100% · $2,820M
FY 2018 Q469.42% · $1,153MUnavailable20.17% · $335M7.28% · $121M3.13% · $52M100% · $1,661M
FY 2019 Q162.53% · $781MUnavailable22.26% · $278M11.29% · $141M3.92% · $49M100% · $1,249M
FY 2019 Q269.25% · $964MUnavailable17.39% · $242M9.84% · $137M3.52% · $49M100% · $1,392M
FY 2019 Q316.99% · $1,139MUnavailable3.56% · $239M2.03% · $136M77.42% · $5,191M100% · $6,705M
FY 2019 Q474.2% · $1,274MUnavailable15.84% · $272M7.92% · $136M2.04% · $35M100% · $1,717M
FY 2020 Q117.87% · $853MUnavailable9.24% · $441M3.18% · $152M69.7% · $3,327M100% · $4,773M
FY 2020 Q295.15% · $745MUnavailable0% · $0M0.13% · $1M4.73% · $37M100% · $783M
FY 2020 Q392.61% · $489MUnavailable0% · $0M0% · $0M7.39% · $39M100% · $528M
FY 2020 Q495.65% · $748MUnavailable0% · $0M0% · $0M4.35% · $34M100% · $782M
FY 2021 Q127.28% · $654MUnavailable63.7% · $1,527M7.05% · $169M1.96% · $47M100% · $2,397M
FY 2021 Q212.08% · $842MUnavailable32.82% · $2,287M2.24% · $156M52.86% · $3,684M100% · $6,969M
FY 2021 Q325.96% · $889MUnavailable68% · $2,329M4.41% · $151M1.64% · $56M100% · $3,425M
FY 2021 Q434.12% · $1,192MUnavailable59.3% · $2,072M4.24% · $148M2.35% · $82M100% · $3,494M
FY 2022 Q126.86% · $861MUnavailable65.55% · $2,101M5.52% · $177M2.06% · $66M100% · $3,205M
FY 2022 Q216.5% · $1,080MUnavailable40.97% · $2,682M2.44% · $160M40.09% · $2,624M100% · $6,546M
FY 2022 Q354.56% · $1,131MUnavailable33.67% · $698M7.72% · $160M4.05% · $84M100% · $2,073M
FY 2022 Q443.32% · $1,323MUnavailable49.74% · $1,519M5.11% · $156M1.83% · $56M100% · $3,054M
FY 2023 Q143.24% · $1,197MUnavailable30.56% · $846M6.32% · $175M19.87% · $550M100% · $2,768M
FY 2023 Q252.19% · $1,241MUnavailable38.48% · $915M6.9% · $164M2.44% · $58M100% · $2,378M
FY 2023 Q345.3% · $1,147MUnavailable45.02% · $1,140M6.4% · $162M3.28% · $83M100% · $2,532M
FY 2023 Q447.36% · $1,159MUnavailable37.19% · $910M6.54% · $160M8.91% · $218M100% · $2,447M
FY 2024 Q124.58% · $1,118MUnavailable25.94% · $1,180M4.07% · $185M45.42% · $2,066M100% · $4,549M
FY 2024 Q242.39% · $1,281MUnavailable45.23% · $1,367M5.66% · $171M6.72% · $203M100% · $3,022M
FY 2024 Q336.85% · $1,191MUnavailable55.54% · $1,795M5.23% · $169M2.38% · $77M100% · $3,232M
FY 2024 Q439.98% · $1,285MUnavailable52.89% · $1,700M5.13% · $165M1.99% · $64M100% · $3,214M
FY 2025 Q113.09% · $991MUnavailable33.1% · $2,506M2.38% · $180M51.44% · $3,895M100% · $7,572M
FY 2025 Q220.94% · $1,176MUnavailable44.6% · $2,505M3.04% · $171M31.42% · $1,765M100% · $5,617M
FY 2025 Q331.22% · $1,288MUnavailable60.54% · $2,498M4.02% · $166M4.22% · $174M100% · $4,126M
FY 2025 Q425.83% · $1,489MUnavailable44.38% · $2,558M2.81% · $162M26.98% · $1,555M100% · $5,764M
FY 2026 Q138.18% · $1,119MUnavailable53.6% · $1,571M6.24% · $183M1.98% · $58M100% · $2,931M
FY 2026 Q220.46% · $1,231MUnavailable34.31% · $2,064M2.84% · $171M42.39% · $2,550M100% · $6,016M

Tracked cash uses · SBC excluded

Sources and calculations

Company filings · USD · Last checked 2026-10-19. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for HCA Healthcare.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

SBC deduction is an optional economic-cost scenario for FCF-based metrics. Missing SBC never becomes zero.

Revenue
Reported revenue from company filings.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Net margin
Reported net income / revenue × 100.
P/E
Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROIC
NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
Capital allocation
Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.
Reported revenue and sources